Neuravi Information

View Top Employees from Neuravi

Neuravi is dedicated to improving clinical outcomes for stroke patients. The company’s stroke therapy platform, the EmboTrap®II Revascularization Device, is CE marked and commercially available in Europe. The device has been available for investigational use only in the United States. Through its investment in the Neuravi Thromboembolic Initiative (NTI), Neuravi supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics, in order to improve patient outcomes in stroke. In April 2017, Codman Neuro announced the acquisition of Neuravi, which is now part of the Johnson and Johnson family of medical device companies. Neuravi was founded in 2009 and is headquartered in Galway, Ireland.

Website	http://www.neuravi.com
Revenue	$8 million
Funding	$59.3 million
Employees	3 (3 on RocketReach)
Founded	2009
Address	Parkmore Business Park West, Galway, Connaught, IE
Phone	+353 91 394 114
Technologies	Microsoft Outlook , Microsoft Exchange Online , Solidworks (view technologies)
Industry	Medical Equipment Manufacturing, Medical Devices & Equipment, Manufacturing
Keywords	Stroke Treatment, Thrombectomy, Endovascular Therapy, Blood Clot Removal, Embolization, Neurology, Ischemic Stroke, Stroke Recovery, Stroke Care, Brain Health, Stroke Prevention, Medical Technology, Healthcare
Competitors	Johnson & Johnson, Medtronic, Abbott, Stryker, Bayer, Boston Scientific, Medline Industries, LP, Cook Medical, Penumbra, Inc., Terumo +33 more (view full list)
SIC	SIC Code 384 Companies, SIC Code 38 Companies
NAICS	NAICS Code 32541 Companies, NAICS Code 325412 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies